Fingerprint
Dive into the research topics of 'Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically